non-Hodgkin's lymphoma

Pfizer halts study of lymphoma drug unlikely to help survival

Pfizer halts study of lymphoma drug unlikely to help survival

Reuters

German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of Pixuvri (pixantrone)

German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of Pixuvri (pixantrone)

Yahoo/PR Newswire

Boehringer Testing Copy of Rituxan in Type of Lymphoma

Boehringer Testing Copy of Rituxan in Type of Lymphoma

Bloomberg

Seattle Genetics to test possible new Adcetris use in late-stage study

Seattle Genetics to test possible new Adcetris use in late-stage study

Yahoo/AP

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting

Yahoo/BusinessWire

Cell Therapeutics soars 24% on EU drug launch

Cell Therapeutics soars 24% on EU drug launch

Marketwatch

Pharmacyclics shares continue climb as analysts project blockbuster sales for cancer drug

Pharmacyclics shares continue climb as analysts project blockbuster sales for cancer drug

Yahoo/AP

Study of Treanda shows great promise for Teva's drug

Study of Treanda shows great promise for Teva's drug

Fierce Pharma

J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal

J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal

Bloomberg

Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments

Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments

Forbes